Showing 121 - 140 results of 214 for search '"statin"', query time: 0.05s Refine Results
  1. 121

    Evolving View of Coronary Artery Calcium: A Personalized Shared Decision-Making Tool in Primary Prevention by Omar Dzaye, Cara Reiter-Brennan, Albert D. Osei, Olusola A. Orimoloye, S. M. Iftekhar Uddin, Mohammadhassan Mirbolouk, Michael J. Blaha

    Published 2019-01-01
    “…The 2018 guidelines, for the first time, clearly recognize the significance of a CAC score of zero, where intensive statin therapy is likely not beneficial and not routinely recommended in selected patients. …”
    Get full text
    Article
  2. 122

    Biomarkers of residual risk and all-cause mortality after acute coronary syndrome. by Anna Toso, Mario Leoncini, Mauro Maioli, Simona Villani, Francesco Bellandi

    Published 2025-03-01
    “…Conclusions: In this population on high-intensity statin therapy only hsCRP and eGFR were independently associated with medium-term mortality. …”
    Get full text
    Article
  3. 123

    Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor by M R Essop, F Seedat, F J Raal

    Published 2023-11-01
    “…Of those on LLT, all were on statin therapy, of which simvastatin at a mean dose of 20 mg daily was the most commonly prescribed LLT. …”
    Get full text
    Article
  4. 124

    Neurofilament Light Chain Assessment in Type 2 Diabetic Patients with Distal Symmetrical Polyneuropathy by Israa Abdelmalik Salem, Sura Ahmed Abdulsattar, Haider Fadhil Alrubaye

    Published 2025-01-01
    “…In patients who were taking antilipidemic statin therapy, the serum levels of the Neurofilament Light Chain were substantially reduced compared to those not receiving it. …”
    Get full text
    Article
  5. 125

    Vascular Protective Effects of Morinda citrifolia Leaf Extract on Postmenopausal Rats Fed with Thermoxidized Palm Oil Diet: Evidence at Microscopic Level by C. L. G. Chong, Faizah Othman, Farida Hussan

    Published 2018-01-01
    “…In addition, we do not recommend the use of statin in the absence of dyslipidemia as it causes PVAT deposition.…”
    Get full text
    Article
  6. 126

    Assessment of Clinical Features in HIV-Infected Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in China by Ying Liu, Yongfu Chen, Yiwei Hao, Jing Xiao, Bei Li, Leidan Zhang, Junyan Han, Hongxin Zhao

    Published 2022-01-01
    “…In PLWH (mean age: 53.6 ± 10.6 years, 95.8% male, and 79.2% on ART), high-density lipoprotein cholesterol was lower than in HIV-negative controls; however, the statin use was more common, the incidence of hypertension was lower, and low-density lipoprotein cholesterol, and the body mass index were significantly lower than in controls. …”
    Get full text
    Article
  7. 127

    Prediction Model of New Onset Atrial Fibrillation in Patients with Acute Coronary Syndrome by Na Wu, Junzheng Li, Xiang Xu, Zhiquan Yuan, Lili Yang, Yanxiu Chen, Tingting Xia, Qin Hu, Zheng Chen, Chengying Li, Ying Xiang, Zhihui Zhang, Li Zhong, Yafei Li

    Published 2023-01-01
    “…Age, admission heart rate, left atrial diameter, right atrial diameter, heart failure, brain natriuretic peptide (BNP) level, less statin use, and no percutaneous coronary intervention (PCI) were independent predictors of NOAF. …”
    Get full text
    Article
  8. 128

    Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry by Michael H. Vu, Glaiza-Mae Sande-Docor, Yulun Liu, Shirling Tsai, Mitul Patel, Chris Metzger, Mehdi H. Shishehbor, Emmanouil S. Brilakis, Nicolas W. Shammas, Peter Monteleone, Subhash Banerjee

    Published 2022-01-01
    “…ISR patients were more frequently on antiplatelet (94.5% vs 89.4%, p=0.007) and statin (68.9% vs 60.3%, p=0.003) therapies. Lesion length was similar (ISR: 145 ± 99 mm vs. non-ISR: 142 ± 99 mm, p=0.55). …”
    Get full text
    Article
  9. 129

    Evaluation of Treatment Patterns and Maintenance Dose Titration Among Patients With Crohn’s Disease Initiating Biologics With 3 Years of Follow-Up by Ruizhi Zhao, Zhijie Ding, Parul Gupta, Laurence Gozalo, Robert Bruette, Victor M. Johnson, Keshia Maughn, Yihang Liu, Sumesh Kachroo

    Published 2023-11-01
    “…**Methods:** This retrospective observational study was conducted using the STATinMED RWD Insights all-payer medical and pharmacy data. …”
    Get full text
    Article
  10. 130

    The relationship between cholesterol levels and thyroid eye disease by Caroline Cardo, Roberto Bernardo Santos, Ana Beatriz Pinotti Pedro Miklos, Sabrina Barbosa Jaconis, João Hamilton Romaldini, Danilo Villagelin

    Published 2025-02-01
    “…Laboratory results and information on smoking habits, statin use and medications affecting lipid profiles during the euthyroid state were analyzed. …”
    Get full text
    Article
  11. 131
  12. 132

    Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study by Morten Lindhardt, Søren Tang Knudsen, Thomas Saxild, Morten Charles, Rikke Borg

    Published 2025-02-01
    “…ACEis/ARBs were prescribed to 65%, statins to 56%, SGTL2is to 14%, and MRAs to 8% of all individuals. …”
    Get full text
    Article
  13. 133

    “Inclisiran: Early LDL-C target achievement in a real-life population” by Francesco Briani, Mauro Bagli, Gabriele Venturi, Francesco Bacchion, Antonio Mugnolo

    Published 2025-03-01
    “…After exclusion of two patients due to statin therapy modification or discontinuation during follow-up, a final number of 31 patients were included. …”
    Get full text
    Article
  14. 134

    Exposure to major coronary heart disease events reduces lung cancer risk: a mendelian randomization study based on a European population by Dongming He, Hongting Lu, Xinhuai Ou, Tiaozhan Zheng, Zhiwen Zheng, Zhanyu Xu, Xiaohong Duan, Shikang Li

    Published 2025-01-01
    “…Relevant single nucleotide polymorphisms (SNPs) associated with MCHDE and lung cancer were carefully selected, with particular attention given to mitigating potential confounders, such as smoking behaviors and statin use. Results The MR analysis, utilizing FinnGen's MCHDE as the exposure factor, revealed a significant reduction in the incidence of non-small cell lung cancer (NSCLC) [odds ratio (OR) 0.893, 95% confidence interval (CI) 0.800–0.998] and small cell lung cancer (SCLC) [OR 0.684, 95% CI 0.500–0.936], highlighting the protective effect of MCHDE against these cancer subtypes. …”
    Get full text
    Article
  15. 135
  16. 136

    Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus by Caroline Pereira Domingueti, Rodrigo Bastos Fóscolo, Janice Sepúlveda Reis, Fernanda Magalhães Freire Campos, Luci Maria S. Dusse, Maria das Graças Carvalho, Karina Braga Gomes, Ana Paula Fernandes

    Published 2016-01-01
    “…Cytokines and haemostatic biomarkers remained associated with nephropathy after adjustments (use of statin, acetylsalicylic acid, angiotensin converting enzyme inhibitor, and angiotensin antagonist). …”
    Get full text
    Article
  17. 137
  18. 138
  19. 139

    Infliximab Induces Increase in Triglyceride Levels in Psoriatic Arthritis Patients by Karla R. Castro, Nádia E. Aikawa, Carla Gonçalves Saad, Júlio C. B. Moraes, Ana C. Medeiros, Licia Maria H. Mota, Clovis A. A. Silva, Eloísa Bonfá, Jozélio F. Carvalho

    Published 2011-01-01
    “…None had dyslipoproteinemia or previous statin use. Total cholesterol (TC) and its fractions, inflammatory markers, and prednisone use were evaluated. …”
    Get full text
    Article
  20. 140